FPR2 and early-onset autosomal dominant Alzheimer disease: FPR2 (also named lipoxin A4 receptor (LXA4R, ALX) is involved in the development of chronic inflammatory diseases, such as atherosclerosis, Alzheimer’s disease, colitis, and NAFLD/NASH, through the regulation of cell proliferation, inflammatory responses, and chemotaxis [38,39].